Cargando…
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among H...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326181/ https://www.ncbi.nlm.nih.gov/pubmed/30380420 http://dx.doi.org/10.1016/j.celrep.2018.10.001 |
_version_ | 1783386256821977088 |
---|---|
author | Wang, Yumeng Xu, Xiaoyan Maglic, Dejan Dill, Michael T. Mojumdar, Kamalika Ng, Patrick Kwok-Shing Jeong, Kang Jin Tsang, Yiu Huen Moreno, Daniela Bhavana, Venkata Hemanjani Peng, Xinxin Ge, Zhongqi Chen, Hu Li, Jun Chen, Zhongyuan Zhang, Huiwen Han, Leng Du, Di Creighton, Chad J. Mills, Gordon B. Camargo, Fernando Liang, Han |
author_facet | Wang, Yumeng Xu, Xiaoyan Maglic, Dejan Dill, Michael T. Mojumdar, Kamalika Ng, Patrick Kwok-Shing Jeong, Kang Jin Tsang, Yiu Huen Moreno, Daniela Bhavana, Venkata Hemanjani Peng, Xinxin Ge, Zhongqi Chen, Hu Li, Jun Chen, Zhongyuan Zhang, Huiwen Han, Leng Du, Di Creighton, Chad J. Mills, Gordon B. Camargo, Fernando Liang, Han |
author_sort | Wang, Yumeng |
collection | PubMed |
description | Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among Hippo genes and the related microRNA (miRNA) regulators, and using functional genomic approaches, we experimentally characterize YAP and TAZ mutation effects and miR-590 and miR-200a regulation for TAZ. Hippo pathway activity is best characterized by a YAP/TAZ transcriptional target signature of 22 genes, which shows robust prognostic power across cancer types. Our elastic-net integrated modeling further reveals cancer-type-specific pathway regulators and associated cancer drivers. Our results highlight the importance of Hippo signaling in squamous cell cancers, characterized by frequent amplification of YAP/TAZ, high expression heterogeneity, and significant prognostic patterns. This study represents a systems-biology approach to characterizing key cancer signaling pathways in the post-genomic era. |
format | Online Article Text |
id | pubmed-6326181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-63261812019-01-09 Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Wang, Yumeng Xu, Xiaoyan Maglic, Dejan Dill, Michael T. Mojumdar, Kamalika Ng, Patrick Kwok-Shing Jeong, Kang Jin Tsang, Yiu Huen Moreno, Daniela Bhavana, Venkata Hemanjani Peng, Xinxin Ge, Zhongqi Chen, Hu Li, Jun Chen, Zhongyuan Zhang, Huiwen Han, Leng Du, Di Creighton, Chad J. Mills, Gordon B. Camargo, Fernando Liang, Han Cell Rep Article Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among Hippo genes and the related microRNA (miRNA) regulators, and using functional genomic approaches, we experimentally characterize YAP and TAZ mutation effects and miR-590 and miR-200a regulation for TAZ. Hippo pathway activity is best characterized by a YAP/TAZ transcriptional target signature of 22 genes, which shows robust prognostic power across cancer types. Our elastic-net integrated modeling further reveals cancer-type-specific pathway regulators and associated cancer drivers. Our results highlight the importance of Hippo signaling in squamous cell cancers, characterized by frequent amplification of YAP/TAZ, high expression heterogeneity, and significant prognostic patterns. This study represents a systems-biology approach to characterizing key cancer signaling pathways in the post-genomic era. 2018-10-30 /pmc/articles/PMC6326181/ /pubmed/30380420 http://dx.doi.org/10.1016/j.celrep.2018.10.001 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Wang, Yumeng Xu, Xiaoyan Maglic, Dejan Dill, Michael T. Mojumdar, Kamalika Ng, Patrick Kwok-Shing Jeong, Kang Jin Tsang, Yiu Huen Moreno, Daniela Bhavana, Venkata Hemanjani Peng, Xinxin Ge, Zhongqi Chen, Hu Li, Jun Chen, Zhongyuan Zhang, Huiwen Han, Leng Du, Di Creighton, Chad J. Mills, Gordon B. Camargo, Fernando Liang, Han Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title_full | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title_fullStr | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title_full_unstemmed | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title_short | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer |
title_sort | comprehensive molecular characterization of the hippo signaling pathway in cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326181/ https://www.ncbi.nlm.nih.gov/pubmed/30380420 http://dx.doi.org/10.1016/j.celrep.2018.10.001 |
work_keys_str_mv | AT wangyumeng comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT xuxiaoyan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT maglicdejan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT dillmichaelt comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT mojumdarkamalika comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT ngpatrickkwokshing comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT jeongkangjin comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT tsangyiuhuen comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT morenodaniela comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT bhavanavenkatahemanjani comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT pengxinxin comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT gezhongqi comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT chenhu comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT lijun comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT chenzhongyuan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT zhanghuiwen comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT hanleng comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT dudi comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT creightonchadj comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT millsgordonb comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT camargofernando comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer AT lianghan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer |